Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Buchan, James (2002)
Publisher: BMJ Publishing Group Ltd.
Languages: English
Types: Article
Subjects: RT
Nursing shortages in the United Kingdom and elsewhere have been a repetitive phenomenon, usually due to an increasing demand for nurses outstripping static or a more slowly growing supply. Demand continues to grow, while projections for supply point to actual reductions in the availability of nurses in some developed and developing countries.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1 Black S, Shinefield H, and the Kaiser Permanente Vaccine Study Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000;9:187­95.
    • 2 French N, Nakiyingi J, Carpenter M, Lugada E, Watera C, Moi K, et al. A double­blind randomised and placebo controlled trial of 23valent pneumococcal polysaccharide vaccine in HIV­1 infected Ugandan adults. Lancet 2000;355:2106­11.
    • 3 Zielen S, Buhring I, Strnad N, Reichenbach J, Hofmann D. Immunogenicity and tolerance of a 7­valent pneumococcal conjugate vaccine in non­responders to the 23­valent pneumococcal vaccine. Infect Immun 2000;68:1435­40.
    • 4 King JC Jr., Vink PE, Farley JJ, Parks M, Smilie M, Madore D, et al. Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non­human immunodeficiency virus­infected children. Pediatr Infect Dis J 1996;15:192­6.
    • 5 O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics 2000;56:965­72
    • 6 Rubins J, Puri A, Loch J, Charboneau D, MacDonald R, Opsatd N, et al. Quality and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998;178:431­40.
    • 7 Eskola J, Antilla M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999;18:543­51.
    • 8 Lucas A, Granoff D. Imperfect memory and the development of Haemophilus influenzae type b disease. Pediatr Infect Dis J 2001;20:235­9.
    • 9 Schmitt HJ, Von Kries R, Hasenflug B, Hermann M, Siedler A, Niessing W, et al. Haemophilus influenzae type b disease impact and effectiveness of diphtheria­tetanus toxoids­acellular pertussis (­inactivated polio)/ Haemophilus influenzae type b combination vaccines. Pediatr Infect Dis J 2001;20:767­74.
    • 10 Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403­9.
    • 11 Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, et al. Projected cost­effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 2000;283:1460­8.
    • 12 Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infection in the United States, 1995­1998. Opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729­35.
    • 1 Global nursing partnerships: strategies for a sustainable nursing workforce. Atlanta: Emory University, 2001. www.nursing.emory.edu
    • 2 Buchan J, Seccombe I, Smith G. Nurses' work: an analysis of the UK nursing labour market. Aldershot: Ashgate Press, 1998.
    • 3 Buchan J. Nurse migration and international recruitment. Nurs Inq 2001;8:203­4.
    • 4 Advisory Committee on Health Human Resources, Health Canada. The nursing strategy for Canada. Ottawa: Health Canada, 2000.
    • 5 Buerhaus P, Staiger D, Auerbach D. Implications of a rapidly aging nurse workforce. JAMA 2000;283:2948­54.
    • 6 Buchan J. Planning for change: developing a policy framework for nursing labour markets. Int Nur Rev 2000; 47:199­206.
    • 7 Irvine D, Evans M. Job satisfaction and turnover amongst nurses: integrating research findings across studies. Nur Res 1995:44:246­53.
    • 8 Baumann A, O'Brien­Pallas L, Armstrong­Stassen M, Blythe J, Bourbonnais R, Cameron S, et al. Commitment and care: the benefits of a healthy workplace for nurses, their patients and the system: Final report. Ottawa: Canadian Health Service Research Foundation, 2001.
    • 9 Aiken L, Smith H, Lake E. Lower Medicare mortality amongst a set of hospitals known for good nursing care Med Care 1994;32:771­87.
    • 10 Brown SA, Grimes DE. A meta­analysis of nurse practitioners and nurse midwives in primary care. Nurs Res 1995;44:332­9.
    • 11 Kinnersley P, Anderson E, Parry K, Clement J, Archard L, Turton P, et al. Randomised control trial of nurse practitioner versus general practitioner care for patients requesting same day consultation in primary care. BMJ 2000;320:1043­8.
    • 12 Buchan J, Ball J, O'May F. If skill mix is the answer, what is the question? J Health Services Res Policy 2000;16:233­8.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article